Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of a Phakic Implantable Collamer Lens (ICL)

NCT: NCT07790965 · NOT_YET_RECRUITING

NCT IDNCT07790965
StatusNOT_YET_RECRUITING
Start Date2026-11
Completion2027-05
SponsorStaar Surgical Company (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, open-labeled, single-site study of a phakic implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.

Frequently Asked Questions

What is Study of a Phakic Implantable Collamer Lens (ICL)?

Study of a Phakic Implantable Collamer Lens (ICL) is a clinical trial registered under NCT07790965. Current status: NOT_YET_RECRUITING.

What is the status of NCT07790965?

The current status of NCT07790965 (Study of a Phakic Implantable Collamer Lens (ICL)) is: NOT_YET_RECRUITING.

When did Study of a Phakic Implantable Collamer Lens (ICL) start?

Study of a Phakic Implantable Collamer Lens (ICL) started on 2026-11.

Related Devices

PMA P030016Lens, intraocular, phakicSTAAR Surgical Company K172375MicroSTAAR Injector System CartridgesSTAAR Surgical Company

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑